TITLE

Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand

AUTHOR(S)
Sirinak, Chawin; Kittikraisak, Wanitchaya; Pinjeesekikul, Duangporn; Charusuntonsri, Pricha; Luanloed, Phinai; Srisuwanvilai, La-ong; Nateniyom, Sriprapa; Akksilp, Somsak; Likanonsakul, Sirirat; Sattayawuthipong, Wanchai; Burapat, Channawong; Varma, Jay K.
PUB. DATE
January 2008
SOURCE
BMC Public Health;2008, Vol. 8, p245
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The occurrence of tuberculosis (TB), human immunodeficiency virus (HIV), and viral hepatitis infections in the same patient poses unique clinical and public health challenges, because medications to treat TB and HIV are hepatotoxic. We conducted an observational study to evaluate risk factors for HBsAg and/or anti-HCV reactivity and to assess differences in adverse events and TB treatment outcomes among HIV-infected TB patients. Methods: Patients were evaluated at the beginning, during, and at the end of TB treatment. Blood samples were tested for aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (BR), complete blood count, and CD4+ T lymphocyte cell count. TB treatment outcomes were assessed at the end of TB treatment according to international guidelines. Results: Of 769 enrolled patients, 752 (98%) had serologic testing performed for viral hepatitis: 70 (9%) were reactive for HBsAg, 237 (31%) for anti-HCV, and 472 (63%) non-reactive for both markers. At the beginning of TB treatment, 18 (26%) patients with HBsAg reactivity had elevated liver function tests compared with 69 (15%) patients non-reactive to any viral marker (p = 0.02). At the end of TB treatment, 493 (64%) were successfully treated. Factors independently associated with HBsAg reactivity included being a man who had sex with men (adjusted odds ratio [AOR], 2.1; 95% confidence interval [CI], 1.1-4.3) and having low TB knowledge (AOR, 1.8; CI, 1.0-3.0). Factors most strongly associated with anti-HCV reactivity were having injection drug use history (AOR, 12.8; CI, 7.0-23.2) and living in Bangkok (AOR, 15.8; CI, 9.4-26.5). The rate of clinical hepatitis and death during TB treatment was similar in patients HBsAg reactive, anti-HCV reactive, both HBsAg and anti-HCV reactive, and non-reactive to any viral marker. Conclusion: Among HIV-infected TB patients living in Thailand, markers of viral hepatitis infection, particularly hepatitis C virus infection, were common and strongly associated with known behavioral risk factors. Viral hepatitis infection markers were not strongly associated with death or the development of clinical hepatitis during TB treatment.
ACCESSION #
51485550

 

Related Articles

  • HIV Monoinfection Is Associated With Increased Aspartate Aminotransferase-to-Platelet Ratio Index, a Surrogate Marker for Hepatic Fibrosis. Price, Jennifer C.; Seaberg, Eric C.; Badri, Sheila; Witt, Mallory D.; D'Acunto, Kristin; Thio, Chloe L. // Journal of Infectious Diseases;3/15/2012, Vol. 205 Issue 6, p1005 

    Background. Although liver disease commonly causes morbidity and mortality among human immunodeficiency virus (HIV)-infected individuals, data are limited on its prevalence in HIV monoinfection. We used the aspartate aminotransferase-to-platelet ratio index (APRI) as a surrogate marker of...

  • Study of a Risk Factor: Blood Exposure Accidents on Health Care Workers. Chifu, Madalina; Chifu, M.; Sin, Anca; Bui, Lucia // Acta Medica Marisiensis;Oct2010, Vol. 56 Issue 5, p439 

    Introduction: Health care workers are exposed to many risk factors during their medical activities. One of these factors is blood exposure accidents who may be very dangerous by the capacity of transmitting infections. The most common infections are viral hepatitis and infection with human...

  • High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil. Blal, C.; Passos, S.; Horn, C.; Georg, I.; Bonecini-Almeida, M.; Rolla, V.; Castro, L. // European Journal of Clinical Microbiology & Infectious Diseases;Jan2005, Vol. 24 Issue 1, p41 

    To determine the prevalence and exposure factors associated with hepatitis B infection in tuberculosis patients with and without HIV type 1 coinfection, the presence of hepatitis B virus serological markers was investigated in a retrospective study. The seroprevalence of hepatitis B virus in...

  • Evidence of at Least Two Introductions of HIV-1 in the Amerindian Warao Population from Venezuela. Rangel, Héctor R.; Maes, Mailis; Villalba, Julian; Sulbarán, Yoneira; De Waard, Jacobus H.; Bello, Gonzalo; Pujol, Flor H. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Background: The Venezuelan Amerindians were, until recently, free of human immunodeficiency virus (HIV) infection. However, in 2007, HIV-1 infection was detected for the first time in the Warao Amerindian population living in the Eastern part of Venezuela, in the delta of the Orinoco river. The...

  • Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Sharma, Surendra K.; Mohan, Alladi // Indian Journal of Medical Research;Mar2013, Vol. 137 Issue 3, p455 

    Globally, tuberculosis (TB) still remains a major public health problem. India is a high TB burden country contributing to 26 per cent of global TB burden. During 1944-1980, TB became treatable and short-course chemotherapy emerged as the standard of care. When TB elimination seemed possible in...

  • Tuberculoza ÅŸi practica stomatologică. O permanentă provocare. CUCULESCU, Marian; BUZEA, Corina-Mona; SLUŞANSCHI, Oana; MAHLER, Beatrice; VLADAU, Andreea; ULMEANU, Ruxandra; MARICA, Constani // Romanian Journal of Medical Practice;2013, Vol. 8 Issue 4, p210 

    The management of infectious-contagious diseases will always incorporate a fundamental component related to prophylaxis, constantly generating new challenges. At present, the main challenges for dental medicine are tuberculosis, viral hepatitis and HIV infection. Knowing the procedures and the...

  • EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF ALOE VERA IN ACUTE VIRAL HEPATITIS. Bhatt, Shaily; Virani, Shalini; Sharma, Monica; Kumar, Harshvardhan; Saxena, K. K. // International Journal of Pharmaceutical Sciences & Research;2014, Vol. 5 Issue 6, p2469 

    Background & objectives: Liver diseases are one of the major causes of disease burden all over world including our country so it is the need of hour to search for alternative drugs for the treatment of liver diseases. Aloe Vera is one of the most popular plants in the world, and is has been used...

  • Commentary: Liver enzymes and all-cause mortality. Fraser, Abigail // International Journal of Epidemiology;Feb2014, Vol. 43 Issue 1, p202 

    No abstract available.

  • A Large Population Histology Study Showing the Lack of Association between ALT Elevation and Significant Fibrosis in Chronic Hepatitis B. Wai-Kay Seto; Ching-Lung Lai; Ip, Philip P. C.; James Fung; Danny Ka-Ho Wong; John Chi-Hang Yuen; Ivan Fan-Ngai Hung; Man-Fung Yuen // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Objective: We determined the association between various clinical parameters and significant liver injury in both hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients. Methods: From 1994 to 2008, liver biopsy was performed on 319 treatment-naïve CHB patients. Histologic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics